BioLineRx Ltd. News Headlines

BLRX 
$2.3035
*  
0.0035
0.15%
Get BLRX Alerts
*Delayed - data as of Feb. 27, 2015 10:08 ET  -  Find a broker to begin trading BLRX now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
View:    BLRX Real Time
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks
Viewing
Filtered By
Ordered By
ARIAD's Iclusig Endorsed by EC for All Approved Indications - Analyst Blog
1/21/2015 2:00:00 PM - Investopedia


BioLineRx Finishes Dose-Escalation in Phase I BL-8040 Study - Analyst Blog
1/8/2015 1:40:00 PM - Investopedia


ALKS Moves Forward, KBIO Craters, GILD Opens Wallet, TRVN For The Long Haul
1/7/2015 2:13:00 AM - RTT News


BioLineRx Out-Licences Skin Lesion Treatment Candidate - Analyst Blog
12/26/2014 3:15:00 AM - Investopedia


BLRX Does A Deal, CRMD Enters Arabia, IG Exceeds Goal, See What's New In GRANIX
12/23/2014 11:36:00 PM - RTT News


Seeking Alpha's Biotech Weekly: A Merck Purchase, Spectacular Auspex, And More
12/19/2014 4:00:00 PM - Seeking Alpha


Look Who's Buying 12.8% Stake In BLRX...
12/16/2014 8:29:00 AM - RTT News


Israeli Biomed-Tech Companies Present Investment Opportunities
4/9/2014 9:10:00 AM - Seeking Alpha


BioLineRx Offers A Wide Range Of Potential Catalysts At An Affordable Valuation
3/11/2014 6:54:00 AM - Seeking Alpha


Will Apoptosis Succeed Where Other Cancer Treatments Haven't? Three Companies Trying
10/25/2013 11:47:00 AM - Seeking Alpha


BioLineRx Offers Investors Multiple Upcoming Catalysts At Currently Depressed Share Price
7/2/2013 10:58:00 AM - Seeking Alpha


China Biotech In Review: Mindray Medical Buys U.S. Ultrasound Company
6/16/2013 2:01:00 AM - Seeking Alpha


AbbVie's Latest Drug Deal Marks A Shift In The Celiac Disease Therapeutics Field
5/20/2013 10:32:00 AM - Seeking Alpha


BioLineRx Pipeline Returns To The Winner's Circle
5/1/2013 8:43:00 AM - Seeking Alpha


Upcoming Trial Data May Help Salvage Bioline Rx
4/3/2013 2:14:00 PM - Seeking Alpha


BioLineRx: Upcoming Catalyst With Potential Multi Billion-Dollar Schizophrenia Drug
1/15/2013 8:01:00 AM - Seeking Alpha


BioLineRx: Israeli Biotech Incubator With Multiple Near-Term Clinical Catalysts
12/6/2012 10:04:00 AM - Seeking Alpha


A Capital-Efficient Prescription For New Drugs: Raghuram "Ram" Selvaraju
11/1/2012 4:52:00 PM - Seeking Alpha


A New And Interesting Addition To The Hep C Clinical Pipeline
10/17/2012 12:30:00 PM - Seeking Alpha


Closer Look: BioLineRx Snags Another Hep-C License Agreement
2/7/2012 10:37:00 AM - Seeking Alpha


BioLineRx: Strong Speculation Bio-Pharma, Strong Acquisition Target
2/3/2012 1:09:00 PM - Seeking Alpha